News

As part of the Bio-Mimetic Project, Dyadic will receive approximately €400,000 to develop enzymes using its patented and proprietary C1 platform technology to degrade and modify lignin. The

The double-blind study is to evaluate the effect of intradermal injection of NP2 Enkephalin on pain reported by subjects suffering from severe intractable pain due to cancer, and

The RandomizEd, OpeNLabel, Phase 3 Study of Carfilzomib Plus DExamethAsone Vs Bortezomib Plus DexamethasOne in Patients With Relapsed Multiple Myeloma (ENDEAVOR) trial is an 888 patient study. Onyx

The study, which incorporates a rapid dose escalation stage and a subsequent efficacy stage, is being conducted at the Abramson Cancer Center of the University of Pennsylvania, according

The patent application entitled, Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders, claims methods for treating pseudobulbar affect or emotional lability using low-dose quinidine

According to the company, each QuickMelt tablet dissolves in the mouth without water and delivers the same amount of cold remedy found in the Cold-EEZE Lozenges. ProPhase Labs

The COBAS TaqMan HIV-1 Test, v2.0, targets two highly conserved regions of the HIV-1 genome and avoids any regions which are current drug targets, according to the company.

The largest health care fraud settlement in US history involves criminal and civil violations involving ten drugs. The company will also plead guilty for not reporting the safety

The expanded XS Technology toolbox provides complementary expression systems that deliver reliable, high yielding cGMP processes, thereby addressing the diversity of microbially-derived proteins. Lonza microbial research and development